News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellular Biomedicine Group (CBMG) Moves To NASDAQ Capital Market



6/19/2014 8:55:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cellular Biomedicine began trading on the NASDAQ Capital Market today. The company is headquartered in Palo Alto, California, and it has two GMP facilities in China: one in Shanghai and the other in WuXi. Cellular Biomedicine develops cell therapy treatments for degenerative diseases and cancer, which it plans to market in China. Previously, Cellular Biomedicine was listed on the OTCQB exchange.

Hey, check out all the research scientist jobs. Post your resume today!

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES